Funding for this research was provided by:
national natural science foundation of china (82001778)
Genomics Platform Construction for Chinese Major Brain Disease-Germ cell tumor (PXM2019_026280_000002)
Article History
Received: 30 July 2021
Accepted: 14 December 2021
First Online: 12 January 2022
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of Beijing Tiantan Hospital.
: All subjects gave their informed consent for inclusion before they participated in the study.
: Not applicable.
: The authors declare no potential competing interest.